Novo Nordisk's Financial Outlook Sparks 10% Plunge in OMX Copenhagen Index

The OMX Copenhagen Benchmark Index dropped over 10% after Novo Nordisk A/S shares fell by 22% due to a disappointing financial outlook revision, reducing its 2025 sales growth fore...